Skip to main content

Peer Review reports

From: Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)

Original Submission
19 Jul 2023 Submitted Original manuscript
26 Sep 2023 Reviewed Reviewer Report
1 Oct 2023 Reviewed Reviewer Report
24 Nov 2023 Author responded Author comments - Keun-Wook Lee
12 Dec 2023 Author responded Author comments - Keun-Wook Lee
Resubmission - Version 2
24 Nov 2023 Submitted Manuscript version 2
31 Dec 2023 Author responded Author comments - Keun-Wook Lee
Resubmission - Version 3
31 Dec 2023 Submitted Manuscript version 3
23 Jan 2024 Reviewed Reviewer Report
29 Jan 2024 Reviewed Reviewer Report
4 Feb 2024 Author responded Author comments - Keun-Wook Lee
Resubmission - Version 4
4 Feb 2024 Submitted Manuscript version 4
Publishing
6 Feb 2024 Editorially accepted
23 Feb 2024 Article published 10.1186/s12885-024-11972-w

You can find further information about peer review here.

Back to article page